ISSN: 1660-2854

Journal Home

Journal Guideline

Neurodegenerative Diseases Q2 Unclaimed

S. Karger AG Switzerland

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Neurodegenerative Diseases is a journal indexed in SJR in Neurology (clinical) and Neurology with an H index of 67. It has an SJR impact factor of 0,648 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,648.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Neurology (clinical) (Q2) Neurology (clinical) (Q2) Neurology (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,648

SJR Impact factor

67

H Index

15

Total Docs (Last Year)

68

Total Docs (3 years)

919

Total Refs

189

Total Cites (3 years)

68

Citable Docs (3 years)

1.93

Cites/Doc (2 years)

61.27

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Parkinsonism and Related Disorders Q2
Journal of Geriatric Psychiatry and Neurology Q2
Frontiers in Neurology Q2
Muscle and Nerve Q2
Journal of Neuromuscular Diseases Q2

Compare this journals

Aims and Scope

Best articles by citations

Campath-1H Treatment of Multiple Sclerosis

Sonographic Alteration of Lenticular Nucleus in Focal Task-Specific Dystonia of Musicians

Hypocapnia Induces Caspase-3 Activation and Increases Abeta Production

Problems and Solutions in the Genetic Analysis of Late-Onset Alzheimer's Disease

Downregulation of beta-Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein: Proteomics-Based Identification in Early-Stage Prion Disease

List of Drugs in Development for Neurodegenerative Diseases

Cortical Brain Biopsy in Long-Term Prognostication of 468 Patients with Possible Normal Pressure Hydrocephalus

List of Drugs in Development for Neurodegenerative Diseases

Presenilin 1 and Cadherins: Stabilization of Cell-Cell Adhesion and Proteolysis-Dependent Regulation of Transcription

Impaired Brain Creatine Kinase Activity in Huntington's Disease

Assessment of the Bioactivity of Antibodies against beta-Amyloid Peptide in vitro and in vivo

Differential Progression of Midbrain Atrophy in Parkinsonism: Longitudinal MRI Study

SHOW MORE ARTICLES

Stem-Cell-Based Strategies for the Treatment of Parkinson's Disease

Genetic Association Study on Colony-Stimulating Factor 1 in Alzheimer's Disease

beta-Amyloid Treatment Sensitizes Mice to Amphetamine-Induced Locomotion but Reduces Response to Caffeine

Course of Irritability, Depression and Apathy in Huntington's Disease in Relation to Motor Symptoms during a Two-Year Follow-Up Period

MPTP Treatment Impairs Tyrosine Hydroxylase Immunopositive Fibers Not Only in the Striatum, but Also in the Amygdala

The Fly as a Model for Neurodegenerative Diseases: Is It Worth the Jump?

Evaluation Tools and Animal Models of Peripheral Neuropathies

Low Serum Vitamin D Levels May Contribute to Gastric Dysmotility in de novo Parkinson's Disease

An Astrocyte Regenerative Response from Vimentin-Containing Cells in the Spinal Cord of Amyotrophic Lateral Sclerosis's Disease-Like Transgenic (G93A SOD1) Mice

Integration of Intention and Outcome for Moral Judgment in Frontotemporal Dementia: Brain Structural Signatures

Frontal Corpus Callosum Alterations in Progressive Supranuclear Palsy but Not in Parkinson's Disease

BACE/APPV717F Double-Transgenic Mice Develop Cerebral Amyloidosis and Inflammation